Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Gynecology

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 97 articles: HTML format Text format

Single Articles

May 2012
1. BARKEN SS , Rebolj M, Andersen ES, Lynge E, et al
   Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
   Int J Cancer. 2012;130:2438-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. DEODHAR K , Sankaranarayanan R, Jayant K, Jeronimo J, et al
   Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India.
   Int J Cancer. 2012 May 14. doi: 10.1002/ijc.27633.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. TRABERT B , Wentzensen N, Yang HP, Sherman ME, et al
   Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
   Int J Cancer. 2012 May 3. doi: 10.1002/ijc.27623.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. OTT MG , Marme F, Moldenhauer G, Lindhofer H, et al
   Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites.
   Int J Cancer. 2012;130:2195-203.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. GAGE JC , Ajenifuja KO, Wentzensen NA, Adepiti AC, et al
   The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.
   Int J Cancer. 2012;130:2111-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
6. ZHAN Y , Wang J, Ma Y, Liu Z, et al
   Serum insulin-like, growth factor binding protein-related protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women.
   Int J Cancer. 2012 Apr 28. doi: 10.1002/ijc.27622.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. JE EM , Kim MR, Min KO, Yoo NJ, et al
   Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
   Int J Cancer. 2012 Apr 24. doi: 10.1002/ijc.27610.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HALEC G , Schmitt M, Dondog B, Sharkhuu E, et al
   Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
   Int J Cancer. 2012 Apr 19. doi: 10.1002/ijc.27605.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. AVILES A , Neri N, Nambo MJ
   Hematological malignancies and pregnancy: Treat or no treat during first trimester.
   Int J Cancer. 2012 Apr 18. doi: 10.1002/ijc.27560.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
10. GADEYNE S , Deboosere P, Vandenheede H, Neels K, et al
    Does birth history account for educational differences in breast cancer mortality? A comparison of pre- and postmenopausal women in Belgium.
    Int J Cancer. 2012 Mar 15. doi: 10.1002/ijc.27538.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. GOK M , van Kemenade FJ, Heideman DA, Berkhof J, et al
    Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
    Int J Cancer. 2012;130:1128-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
12. SOPO M , Anttila M, Sallinen H, Tuppurainen L, et al
    Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma.
    Int J Cancer. 2012 Feb 15. doi: 10.1002/ijc.27495.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. AZERKAN F , Sparen P, Sandin S, Tillgren P, et al
    Cervical screening participation and risk among Swedish-born and immigrant women in Sweden.
    Int J Cancer. 2012;130:937-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ROOSSINK F , Wieringa HW, Noordhuis MG, Ten Hoor KA, et al
    The role of ATM and 53BP1 as predictive markers in cervical cancer.
    Int J Cancer. 2012 Feb 10. doi: 10.1002/ijc.27488.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. GIRI A , Hartmann K Dr
    Re: A prospective investigation of coffee drinking and endometrial cancer incidence.
    Int J Cancer. 2012 Feb 9. doi: 10.1002/ijc.27484.
    PubMed     Text format     Related articles   
    
    
    
    January 2012
16. LACEY JV JR , Chia VM, Rush BB, Carreon DJ, et al
    Incidence rates of endometrial hyperplasia, endometrial cancer, and hysterectomy from 1980 to 2003 within a large prepaid health plan.
    Int J Cancer. 2012 Jan 30. doi: 10.1002/ijc.27457.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. DE JONG RA , Boerma A, Boezen HM, Mourits MJ, et al
    Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas.
    Int J Cancer. 2012 Jan 27. doi: 10.1002/ijc.27449.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HORIUCHI A , Hayashi T, Kikuchi N, Hayashi A, et al
    Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1alpha to a hypoxia-induced, methylation free hypoxia response element (HRE) of S100A4 gene.
    Int J Cancer. 2012 Jan 27. doi: 10.1002/ijc.27448.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. REUSCHENBACH M , Seiz M, von Knebel Doeberitz C, Vinokurova S, et al
    Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells.
    Int J Cancer. 2012;130:388-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. RUDOLPH A , Hein R, Hoffmeister M, Forsti A, et al
    Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy.
    Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27428.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MARKOWSKI DN , Bartnitzke S, Loning T, Drieschner N, et al
    MED12 mutations in uterine fibroids - their relationship to cytogenetic subgroups.
    Int J Cancer. 2012 Jan 5. doi: 10.1002/ijc.27424.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
22. JE Y , Giovannucci E
    Coffee drinking and risk of endometrial cancer: Findings from a large up-to-date meta-analysis.
    Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. LE BOEUF F , Niknejad N, Wang J, Auer R, et al
    Sensitivity of cervical carcinoma cells to vesicular stomatitis virus induced oncolysis: Potential role of human papilloma virus infection.
    Int J Cancer. 2011 Dec 15. doi: 10.1002/ijc.27404.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. VERMEIJ R , Leffers N, Hoogeboom BN, Hamming IL, et al
    Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer, a single arm phase II study.
    Int J Cancer. 2011 Dec 3. doi: 10.1002/ijc.27388.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
25. XU M , Rettig M, Sudlow G, Wang B, et al
    Preclinical evaluation of mab CC188 for ovarian cancer imaging.
    Int J Cancer. 2011 Nov 30. doi: 10.1002/ijc.27380.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. D'SOUZA G , Burk RD, Zhong Y, Minkoff H, et al
    Cervicovaginal HPV infection before and after hysterectomy: Evidence of different tissue tropism for oncogenic and non-oncogenic HPV types in a cohort of HIV-positive and HIV-negative women.
    Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27363.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. FERGUSON R , Ramanakumar AV, Koushik A, Coutlee F, et al
    Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
    Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27356.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LAVOUE V , Cabillic F, Toutirais O, Thedrez A, et al
    Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vgamma9Vdelta2 T cells impaired by the prostaglandin E2 immunosuppressive factor: Implications for immunotherapy.
    Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27353.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HIROKI E , Suzuki F, Akahira JI, Nagase S, et al
    MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
    Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27345.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
30. KHODAKARAMI N , Clifford GM, Yavari P, Farzaneh F, et al
    Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran.
    Int J Cancer. 2011 Oct 31. doi: 10.1002/ijc.26488.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. MARME F , Hielscher T, Hug S, Bondong S, et al
    Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
    Int J Cancer. 2011 Oct 27. doi: 10.1002/ijc.27329.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. FELIX AS , Stone RA, Chivukula M, Bowser R, et al
    Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.
    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27317.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. RUSSO J , Santucci-Pereira J, de Cicco RL, Sheriff F, et al
    Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.
    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27323.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. JAAKKOLA S , Pukkala E, Lyytinen HK, Ylikorkala O, et al
    Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.
    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27321.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. GUNTER MJ , Schaub JA, Xue X, Freedman ND, et al
    A prospective investigation of coffee drinking and endometrial cancer incidence.
    Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26482.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
36. CHEN RJ , Chen SU, Chou CH, Lin MC, et al
    Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26476.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. VANNI T , Mendes Luz P, Grinsztejn B, Veloso VG, et al
    Cervical cancer screening among HIV-infected women: An economic evaluation in a middle-income country.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26472.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. VUYST HD , Ndirangu G, Moodley M, Tenet V, et al
    Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa.
    Int J Cancer. 2011 Sep 29. doi: 10.1002/ijc.26470.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. YANG HP , Trabert B, Murphy MA, Sherman ME, et al
    Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study.
    Int J Cancer. 2011 Sep 29. doi: 10.1002/ijc.26469.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. HARRIS HR , Cramer DW, Vitonis AF, Depari M, et al
    Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26455.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. LUDVIGSSON JF , West J, Ekbom A, Stephansson O, et al
    Reduced risk of breast, endometrial, and ovarian cancer in women with celiac disease.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26454.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SEIBOLD P , Hein R, Schmezer P, Hall P, et al
    Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
    Int J Cancer. 2011;129:1467-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. NICKLIN J , Janda M, Gebski V, Jobling T, et al
    The utility of serum CA-125 in predicting extra-uterine disease in apparent early stage endometrial cancer.
    Int J Cancer. 2011 Sep 14. doi: 10.1002/ijc.26433.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BIGGAR RJ , Wohlfahrt J, Melbye M
    Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix.
    Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26424.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ORENGO AM , Fabbi M, Miglietta L, Andreani C, et al
    Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor.
    Int J Cancer. 2011;129:1116-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
46. MOUSAVI SM , Sundquist K, Hemminki K
    Morbidity and mortality in gynecological cancers among first- and second-generation immigrants in Sweden.
    Int J Cancer. 2011 Aug 26. doi: 10.1002/ijc.26395.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LIN A , Zhang X, Xu HH, Xu DP, et al
    HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26375.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. FUJISAWA T , Joshi BH, Puri RK
    IL-13 regulates cancer invasion and metastasis through IL-13Ralpha2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26366.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. FEKETE T , Raso E, Pete I, Tegze B, et al
    Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26364.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ZHANG X , Wang C, Wang L, Du L, et al
    Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26360.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. CRUMP C , Sundquist K, Winkleby MA, Sieh W, et al
    Gestational age at birth and risk of testicular cancer.
    Int J Cancer. 2011 Aug 16. doi: 10.1002/ijc.26371.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. CHANG YJ , Chen HC, Lee BH, You SL, et al
    Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia.
    Int J Cancer. 2011;129:965-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. DECRAUSAZ L , Domingos-Pereira S, Duc M, Bobst M, et al
    Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.
    Int J Cancer. 2011;129:762-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. VANNI T , Legood R, Franco EL, Villa LL, et al
    Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.
    Int J Cancer. 2011;129:671-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
55. FISCHER E , Grunberg J, Cohrs S, Hohn A, et al
    L1-CAM-targeted antibody therapy and (177) Lu-Radioimmunotherapy of disseminated ovarian cancer.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26321.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. YU VM , Marion CM, Austria TM, Yeh J, et al
    Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells.
    Int J Cancer. 2011 Jul 25. doi: 10.1002/ijc.26309.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
57. CAMPOS NG , Kim JJ, Castle PE, Ortendahl JD, et al
    Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.
    Int J Cancer. 2011 Jun 29. doi: 10.1002/ijc.26269.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. DAVAASAMBUU G , Cui X, Feskanich D, Hankinson SE, et al
    Milk, dairy intake and risk of endometrial cancer: A twenty six-year follow-up.
    Int J Cancer. 2011 Jun 29. doi: 10.1002/ijc.26265.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. PLUMMER M , Peto J, Franceschi S
    Time since first sexual intercourse and the risk of cervical cancer.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26250.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. GRAM IT , Lukanova A, Brill I, Braaten T, et al
    Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
    Int J Cancer. 2011 Jun 15. doi: 10.1002/ijc.26235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. GREEN J , Czanner G, Reeves G, Watson J, et al
    Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
62. HERNANDEZ-PLATA E , Ortiz CS, Marquina-Castillo B, Medina-Martinez I, et al
    Over expression of Na(V) 1.6 channels is associated with the invasion capacity of human cervical cancer.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26210.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. JUNG HS , Erkin OC, Kwon MJ, Kim SH, et al
    Human papillomavirus E6/E7 siRNA potentiates the therapeutic effect of cisplatin in cervical cancer cell lines In vitro and In vivo.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26197.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. BOYERINAS B , Park SM, Murmann AE, Gwin K, et al
    Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of MDR1.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26190.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. THERIAULT BL , Pajovic S, Bernardini MQ, Shaw PA, et al
    Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26189.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. ROUETTE A , Parent S, Girouard J, Leblanc V, et al
    Cisplatin increases B-cell lymphoma 2 expression via activation of protein kinase C and AKT2 in endometrial cancer cells.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26183.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. TERLOU A , Kleinjan A, Beckmann I, Heijmans-Antonissen C, et al
    Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia.
    Int J Cancer. 2011;128:2463-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. RAZAVI P , Lee E, Bernstein L, Van Den Berg D, et al
    Variations in sex hormone metabolism genes, postmenopausal hormone therapy, and risk of endometrial cancer.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26163.
    PubMed     Text format     Related articles   
    
    
    
    
69. ZAINEDDIN AK , Vrieling A, Buck K, Becker S, et al
    Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and HER2 receptor status.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26157.
    PubMed     Text format     Related articles   
    
    
    
    
70. DECRAUSAZ L , Goncalves AR, Domingos-Pereira S, Pythoud C, et al
    A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.
    Int J Cancer. 2011;128:2105-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. HAMMOUDA D , Clifford GM, Pallardy S, Ayyach G, et al
    Human papillomavirus infection in a population-based sample of women in Algiers, Algeria.
    Int J Cancer. 2011;128:2224-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
72. LLAURADO M , Abal M, Castellvi J, Cabrera S, et al
    ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Int J Cancer. 2011 Apr 25. doi: 10.1002/ijc.26148.
    PubMed     Text format     Related articles   
    
    
    
    
73. YAO Q , Cao S, Li C, Mengesha A, et al
    Micro-RNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction.
    Int J Cancer. 2011;128:1783-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. DICK MG , Versmold B, Engel C, Meindl A, et al
    Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1-mutation carriers.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26134.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. PARK Y , Kim Y, Lee EY, Lee JH, et al
    Reference ranges for HE4 and CA125 in a large asian population by automated assays and diagnostic performances for ovarian cancer.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26129.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. KOSAKA N , Mitsunaga M, Longmire MR, Choyke PL, et al
    Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green.
    Int J Cancer. 2011 Apr 5. doi: 10.1002/ijc.26113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
77. ZIOGAS AC , Gavalas NG, Tsiatas M, Tsitsilonis O, et al
    VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor type 2.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26094.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. GANAPATHY E , Su F, Meriwether D, Devarajan A, et al
    D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the anti-oxidant enzyme MnSOD.
    Int J Cancer. 2011 Mar 21. doi: 10.1002/ijc.26079.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. LUKANOVA A , Surcel HM, Lundin E, Kaasila M, et al
    Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.
    Int J Cancer. 2011 Mar 16. doi: 10.1002/ijc.26070.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. AULT KA , Joura EA, Kjaer SK, Iversen OE, et al
    Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
    Int J Cancer. 2011;128:1344-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. STOLER MH , Vichnin MD, Ferenczy A, Ferris DG, et al
    The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials.
    Int J Cancer. 2011;128:1354-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. CHUNG TK , Lau TS, Cheung TH, Yim SF, et al
    Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26060.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. RIJKAART DC , Berkhof J, van Kemenade FJ, Coupe VM, et al
    Evaluation of 14 triage strategies for HPV DNA positive women in population-based cervical screening.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26056.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. CASTRO FA , Ivansson EL, Schmitt M, Juko-Pecirep I, et al
    Contribution of TMC6 and 8 (EVER1 and2) variants to cervical cancer susceptibility.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26016.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
85. WANG H , Song X, Zhang H, Zhang J, et al
    Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26013.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. PULIPATI NR , Jin Q, Liu X, Sun B, et al
    Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25954.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KRYCZEK I , Liu S, Roh M, Vatan L, et al
    Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25967.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. YAMAMURA S , Matsumura N, Mandai M, Huang Z, et al
    The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25961.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. SAHASRABUDDHE VV , Bhosale RA, Kavatkar AN, Nagwanshi CA, et al
    Comparison of visual inspection with acetic acid (VIA) and cervical cytology to detect high grade cervical neoplasia among HIV-infected women in India.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25971.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
90. WANG PH , Ko JL, Yang SF, Lin LY, et al
    Implication of human nonmetastatic clone 23 Type 1 and its downstream gene lipocalin 2 in metastasis and patient's survival of cancer of uterine cervix.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25936.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. LOPEZ TV , Lappin TR, Maxwell P, Shi Z, et al
    Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25935.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
92. TERLOU A , Seters M, Kleinjan A, Heijmans-Antonissen C, et al
    Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
    Int J Cancer. 2010;127:2831-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. GOARD CA , Mather RG, Vinepal B, Clendening JW, et al
    Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.
    Int J Cancer. 2010;127:2936-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. WANG X , Meyers C, Guo M, Zheng ZM, et al
    Up-regulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
95. HEYMANS J , Benoy IH, Poppe W, Depuydt CE, et al
    Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
96. TAYLOR S , Wang C, Wright TC, Denny L, et al
    A comparison of HPV testing of clinician-collected and self-collected samples during follow-up after screen-and-treat.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
97. GUERRERO D , Guarch R, Ojer A, Casas JM, et al
    Differential hypermethylation of genes in vulvar cancer and lichen sclerosus coexisting or not with vulvar cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: